Medscape Oncology

Does Breast Cancer Risk REACT to Celecoxib?


Listen Later

Does this COX-2 inhibitor alter breast cancer risk? Dr Kathy Miller discusses the results of the REACT trial with its primary investigator, Dr Charles Coombes.
...more
View all episodesView all episodes
Download on the App Store

Medscape OncologyBy Medscape